ID: MRFR/HC/5690-HCR | 70 Pages | Author: Kinjoll Dey | March 2024
Table of Content:
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Opportunities
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porter’s Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Bargaining Power of Buyers
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
6 China Fertility Services Market, By Underlying Cause
6.1 Overview
6.1.1 Female Infertility
6.1.2 Male Infertility
7 China Fertility Services Market, By Treatment Type
7.1 Overview
7.1.1 Assisted Reproductive Technology (ART)
7.1.2 Infertility Drugs
8 China Fertility Services Market, By End User
8.1 Overview
8.1.1 Fertility Clinics
8.1.2 Hospitals
8.1.3 Clinical Research Institutes
8.1.4 Others
9 China Fertility Services Market, By Region
9.1 Overview
9.2 East China
9.3 South East China
9.4 West China
9.5 North China
9.6 Central China
10 Competitive Landscape
10.1 Competitive Scenario
10.1.1 Competitive Overview of the China Fertility Services Market
11 Company Profiles
11.1 Cook Medical
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Company Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 CooperSurgical
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Company Offering
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Ferring Pharmaceuticals
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Company Offering
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Irvine Scientific sales Company, Inc
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Company Offering
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Merck KGaA
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Company Offering
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Vitrolife
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Company Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Others
12 Appendix
12.1 Discussion Blue Print
12.2 References